NCT00590044View on ClinicalTrials.gov

Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

August 31, 2008

Conditions
Diabetic Ketoacidosis
Interventions
DRUG

insulin glargine+ glulisine

Daily insulin glargine + glulisine before meals

DRUG

NPH + Regular insulin

Split-mixed NPH + Regular insulin twice daily

Trial Locations (2)

30303

Grady Memorial Hospital, Atlanta

55455

University of Minnesota School of Medicine, Minneapolis

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Emory University

OTHER